The closing price of Twist Bioscience Corp (NASDAQ: TWST) was $33.83 for the day, up 0.56% from the previous closing price of $33.64. In other words, the price has increased by $+0.19 from its previous closing price. On the day, 634162 shares were traded.
Ratios:
Our analysis of TWST’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 5.51 and its Current Ratio is at 5.98. In the meantime, Its Debt-to-Equity ratio is 0.16 whereas as Long-Term Debt/Eq ratio is at 0.13.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Goldman on January 17, 2024, Upgraded its rating to Buy and sets its target price to $45 from $25 previously.
On September 27, 2023, Berenberg started tracking the stock assigning a Buy rating and target price of $27.
On January 05, 2023, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $33.Scotiabank initiated its Sector Outperform rating on January 05, 2023, with a $33 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 14 ’24 when Cho Dennis sold 93 shares for $34.60 per share. The transaction valued at 3,218 led to the insider holds 81,363 shares of the business.
Leproust Emily M. sold 1,487 shares of TWST for $55,658 on Mar 06 ’24. The Chief Executive Officer now owns 516,409 shares after completing the transaction at $37.43 per share. On Mar 06 ’24, another insider, Green Paula, who serves as the SVP of Human Resources of the company, sold 600 shares for $37.43 each. As a result, the insider received 22,458 and left with 92,850 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TWST now has a Market Capitalization of 1.96B and an Enterprise Value of 1.74B. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.46 while its Price-to-Book (P/B) ratio in mrq is 3.31. Its current Enterprise Value per Revenue stands at 6.62 whereas that against EBITDA is -10.07.
Stock Price History:
Over the past 52 weeks, TWST has reached a high of $43.21, while it has fallen to a 52-week low of $11.46. The 50-Day Moving Average of the stock is 36.49, while the 200-Day Moving Average is calculated to be 25.71.
Shares Statistics:
TWST traded an average of 1.05M shares per day over the past three months and 723.8k shares per day over the past ten days. A total of 57.56M shares are outstanding, with a floating share count of 55.29M. Insiders hold about 4.37% of the company’s shares, while institutions hold 109.15% stake in the company. Shares short for TWST as of Feb 29, 2024 were 12.4M with a Short Ratio of 11.75, compared to 12.33M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 21.44% and a Short% of Float of 28.11%.
Earnings Estimates
The firm’s stock currently is rated by 9 analysts. On average, analysts expect EPS of -$0.81 for the current quarter, with a high estimate of -$0.75 and a low estimate of -$0.86, while EPS last year was -$1.04. The consensus estimate for the next quarter is -$0.77, with high estimates of -$0.69 and low estimates of -$0.84.
Analysts are recommending an EPS of between -$2.84 and -$3.24 for the fiscal current year, implying an average EPS of -$3.08. EPS for the following year is -$2.7, with 9 analysts recommending between -$1.97 and -$3.29.
Revenue Estimates
A total of 9 analysts have provided revenue estimates for TWST’s current fiscal year. The highest revenue estimate was $299.96M, while the lowest revenue estimate was $290.5M, resulting in an average revenue estimate of $293.24M. In the same quarter a year ago, actual revenue was $245.11M, up 19.60% from the average estimate. Based on 9 analysts’ estimates, the company’s revenue will be $354.11M in the next fiscal year. The high estimate is $384.87M and the low estimate is $340.4M. The average revenue growth estimate for next year is up 20.80% from the average revenue estimate for this year.
